Who
Michael Brian Bell
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Guardant Health; Chief Financial Officer, CareDx.
In numbers
- Trades disclosed
- 298
- Buys
- 1
- Sells
- 14
- Bought
- $1,323
- Sold
- $15.7M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Apr 2017
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —2,085 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,871 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $684K3,914 at $174.75 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,085 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,871 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —2,084 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,870 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,084 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,870 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $668K3,914 at $170.77 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,084 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,870 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —2,084 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,870 at $0.00 | filing |
News
Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026Guardant Health (NASDAQ:GH) Director Sells $19,242.08 in StockGH · themarketsdaily.com · 19 Oct 2026Guardant Health (NASDAQ:GH) Stock Price Down 6.4% – Time to Sell?GH · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Michael Brian Bell; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.